These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29990625)

  • 1. Targeting mTORs by omega-3 fatty acids: A possible novel therapeutic strategy for neurodegeneration?
    Shirooie S; Nabavi SF; Dehpour AR; Belwal T; Habtemariam S; Argüelles S; Sureda A; Daglia M; Tomczyk M; Sobarzo-Sanchez E; Xu S; Nabavi SM
    Pharmacol Res; 2018 Sep; 135():37-48. PubMed ID: 29990625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration.
    Querfurth H; Lee HK
    Mol Neurodegener; 2021 Jul; 16(1):44. PubMed ID: 34215308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fighting neurodegeneration with rapamycin: mechanistic insights.
    Bové J; Martínez-Vicente M; Vila M
    Nat Rev Neurosci; 2011 Jul; 12(8):437-52. PubMed ID: 21772323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DHA/EPA (Omega-3) and LA/GLA (Omega-6) as Bioactive Molecules in Neurodegenerative Diseases.
    Kousparou C; Fyrilla M; Stephanou A; Patrikios I
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic induction of autophagy to modulate neurodegenerative disease progression.
    Hochfeld WE; Lee S; Rubinsztein DC
    Acta Pharmacol Sin; 2013 May; 34(5):600-4. PubMed ID: 23377551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel compounds for the modulation of mTOR and autophagy to treat neurodegenerative diseases.
    Heras-Sandoval D; Pérez-Rojas JM; Pedraza-Chaverri J
    Cell Signal; 2020 Jan; 65():109442. PubMed ID: 31639492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTOR: on target for novel therapeutic strategies in the nervous system.
    Maiese K; Chong ZZ; Shang YC; Wang S
    Trends Mol Med; 2013 Jan; 19(1):51-60. PubMed ID: 23265840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staufen1 in Human Neurodegeneration.
    Paul S; Dansithong W; Figueroa KP; Gandelman M; Scoles DR; Pulst SM
    Ann Neurol; 2021 Jun; 89(6):1114-1128. PubMed ID: 33745139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials.
    Avallone R; Vitale G; Bertolotti M
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Converging evidence in support of omega-3 polyunsaturated fatty acids as a potential therapy for Huntington's disease symptoms.
    Vega OM; Cepeda C
    Rev Neurosci; 2021 Dec; 32(8):871-886. PubMed ID: 33818039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commonalities in Biological Pathways, Genetics, and Cellular Mechanism between Alzheimer Disease and Other Neurodegenerative Diseases: An In Silico-Updated Overview.
    Ahmad K; Baig MH; Mushtaq G; Kamal MA; Greig NH; Choi I
    Curr Alzheimer Res; 2017; 14(11):1190-1197. PubMed ID: 28164765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated mTOR-dependent signaling in neurodegeneration or carcinogenesis: implication for Alzheimer's disease and brain tumors.
    Wang S; Wu J; Nie SD; Bereczki E; Pei JJ
    J Alzheimers Dis; 2013; 37(3):495-505. PubMed ID: 23948902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration.
    Heras-Sandoval D; Pérez-Rojas JM; Hernández-Damián J; Pedraza-Chaverri J
    Cell Signal; 2014 Dec; 26(12):2694-701. PubMed ID: 25173700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 fatty acids in neurodegenerative diseases: focus on mitochondria.
    Eckert GP; Lipka U; Muller WE
    Prostaglandins Leukot Essent Fatty Acids; 2013 Jan; 88(1):105-14. PubMed ID: 22727983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical Exercise-Induced Myokines in Neurodegenerative Diseases.
    Lee B; Shin M; Park Y; Won SY; Cho KS
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant Modulation of mTOR and Sirtuin Pathways in Age-Related Neurodegenerative Diseases.
    Abdullah A; Mohd Murshid N; Makpol S
    Mol Neurobiol; 2020 Dec; 57(12):5193-5207. PubMed ID: 32865663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration.
    Janssen CI; Kiliaan AJ
    Prog Lipid Res; 2014 Jan; 53():1-17. PubMed ID: 24334113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega fatty acid ratios and neurodegeneration in a healthy environment.
    Dere Yelken H; Elci MP; Turker PF; Demirkaya S
    Prostaglandins Other Lipid Mediat; 2024 Feb; 170():106799. PubMed ID: 37977351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases.
    Lorente-Cebrián S; Costa AG; Navas-Carretero S; Zabala M; Laiglesia LM; Martínez JA; Moreno-Aliaga MJ
    J Physiol Biochem; 2015 Jun; 71(2):341-9. PubMed ID: 25752887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.
    Maiese K
    Biochem Soc Trans; 2018 Apr; 46(2):351-360. PubMed ID: 29523769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.